Phthalates and Pubertal Gynecomastia: DEHP and MEHP Effects
This paper reviews a study by Durmaz et al. (2010) investigating the relationship between plasma phthalate levels — specifically di-(2-ethylhexyl)-phthalate (DEHP) and its metabolite mono-(2-ethylhexyl)-phthalate (MEHP) — and pubertal gynecomastia in adolescent males. The review covers the study's abstract, introduction, materials and methods, results, discussion, and conclusion. Forty patients aged 11–15 were analyzed, with 19 diagnosed with pubertal gynecomastia and 21 serving as controls. Results showed statistically significantly higher plasma DEHP and MEHP levels in the gynecomastia group, suggesting these industrial chemicals — known for antiandrogenic and estrogenic properties — may play an etiologic role in the condition. The paper emphasizes the need for larger-scale studies to confirm a causal relationship.
- Abstract Overview: Study aims, chemicals examined, and key findings
- Introduction to Pubertal Gynecomastia and Phthalates: Hormonal mechanisms and DEHP's role in gynecomastia
- Materials and Methods: Participant selection, instruments, and measurement procedures
- Results: Significantly higher DEHP and MEHP levels in gynecomastia group
- Discussion: DEHP toxicity, environmental contamination, and animal study comparisons
- Conclusion: Need for larger studies; chemicals linked to hormonal disorders
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper follows the structure of the source article section by section, demonstrating disciplined organization and a clear analytical framework for summarizing a scientific study.
- Each section pairs a summary of the study's content with a direct supporting quotation, reinforcing claims with textual evidence and maintaining academic rigor.
- The paper contextualizes the study's limitations honestly — noting the small sample size and the absence of a confirmed cause-effect relationship — which shows critical thinking beyond simple description.
Key academic technique demonstrated
The paper demonstrates systematic article critique by walking through each section of a peer-reviewed study and evaluating both the findings and the methodology. This section-by-section approach, paired with integrated direct quotations and brief analytical commentary, is a fundamental technique in scientific literature review at the undergraduate level.
Structure breakdown
The paper is organized to mirror the source study: it opens with the abstract, moves through the introduction, materials and methods, results, and discussion, and closes with a conclusion. Each section contains a descriptive summary followed by a key quoted passage, creating a consistent dual-layer structure of paraphrase and evidence throughout.
Abstract Overview
This paper reviews the health effects of phthalates as examined in a study by Durmaz et al. (2010). Phthalates are a group of industrial chemicals with numerous uses, including in personal-care products and plastic supplies. The most frequently used chemical discussed in the study is di-(2-ethylhexyl)-phthalate (DEHP), which is known to possess estrogenic effects, antiandrogenic effects, or both. Another chemical the authors examine is mono-(2-ethylhexyl)-phthalate (MEHP), the main metabolite of DEHP. As the authors state, "Mono-(2-ethylhexyl)-phthalate (MEHP) is the main metabolite of DEHP. In this study, we aimed to determine the plasma DEHP and MEHP levels in pubertal gynecomastia cases" (Durmaz et al., 2010, p. e122).
The study group consists of 40 newly diagnosed cases of pubertal gynecomastia admitted to a university children's hospital. Age-matched children without pubertal gynecomastia or any other hormone-related disorder were used as the control group. Both MEHP and DEHP plasma levels were measured using high-performance liquid chromatography, and serum hormone levels were assessed through a physician's evaluation. The results provided valuable insight into plasma DEHP and MEHP levels: those with pubertal gynecomastia had consistently higher plasma MEHP and DEHP levels, indicating a statistically noteworthy connection between these chemicals and the condition. Although the authors state that no direct connection could be established between plasma hormone levels and DEHP and MEHP levels, the evidence suggests that pubertal gynecomastia may be affected by exposure to both chemicals.
The conclusion of the abstract offers a brief synopsis of the findings: "DEHP, which has antiandrogenic or estrogenic effects, may be an etiologic factor in pubertal gynecomastia. These results may pioneer larger-scale studies on the etiologic role of DEHP in pubertal gynecomastia" (Durmaz et al., 2010, p. e122).
Introduction to Pubertal Gynecomastia and Phthalates
Pubertal gynecomastia involves the benign growth of male breast tissue along with increased proliferation of ductal elements. Due in part to the growing presence of chemicals in food and consumer products, pubertal gynecomastia is a frequently encountered problem, occurring in approximately 65% of teenage males. Since male breast tissue contains both androgen and estrogen receptors, any chemicals with estrogenic properties will contribute to estrogen-related proliferation. Androgens inhibit breast tissue proliferation, while estrogens stimulate it. Pubertal gynecomastia produces an imbalance between these two hormones, leading to excess estrogen within the breast tissues and subsequent tissue proliferation. As the authors note, this imbalance may be attributable to "excessive estrogen activity, deficient androgen activity, increase aromatase enzyme activity, or a combination of these effects on breast tissue" (Durmaz et al., 2010, p. e123).
DEHP is reported to be an androgen antagonist, meaning it depletes androgens within the body and, in the context of pubertal gynecomastia, within breast tissue. Since the disorder requires androgen depletion for estrogens to stimulate breast tissue proliferation, DEHP may be a direct contributing factor. The introduction also discusses a possible estrogenic effect from DEHP, although prior studies have attempted to examine this correlation. The authors outline the study's purpose: to identify the effects of MEHP and DEHP on hormone levels in patients and to evaluate the impact of these chemicals on those diagnosed with pubertal gynecomastia.
The authors emphasize the novelty of their investigation: "As far as we know there is no report in which the authors investigated the relationship between DEHP/MEHP levels and pubertal gynecomastia, which develops as a result of an imbalance between androgenic and estrogenic activity" (Durmaz et al., 2010, p. e123).
Materials and Methods
This section covers the materials utilized and the methods employed to measure and record data during the study. Of the forty patients studied, 19 had pubertal gynecomastia and the other 21 were healthy, showing no signs of endocrine disorder. All subjects were male and between 11 and 15 years of age. Blood samples were taken from the left arm cubital vein using a stainless steel needle.
Several hormone screening kits were used for testing. As described by the authors, "Commercial kits for luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, prolactin, thyrotropin, free triiodothyronine (FT3), and free thyroxine (FT4) were purchased from Abbott Architect (Abbott Park, IL), and the kits for the sex hormone-binding globulin (SHBG) were purchased from Zentech" (Durmaz et al., 2010, p. e124). These kits included not only estradiol but also other key hormone screenings such as prolactin, which directly affects milk production in humans. Sample protection was a critical measure; samples were wrapped in aluminum foil, then subjected to centrifugation and stored frozen.
In addition to the hormone screening kits, DEHP and MEHP standards were purchased from laboratories. Serum hormone levels were determined using the 2-step chemiluminescence microparticle immunoassay method. Statistical analysis was performed using SPSS 13.0 software. Regarding instrumentation, the authors note that "Determination of DEHP and MEHP concentrations was conducted by HPLC equipped with an auto sampler (Hewlett Packard Agilent 1100 Series, Vienna, Austria) using a UV detector (230 nm)" (Durmaz et al., 2010, p. e124).
Conclusion
DEHP and MEHP appear to play a role in pubertal gynecomastia. However, because relatively little research exists to generate a definitive answer, the correlation between these chemicals and hormonal imbalance remains unclear. Numerous foods and consumer products contain chemicals that have not yet been thoroughly studied. With the growing number of cases of hormonal disorders such as pubertal gynecomastia, it is becoming increasingly important to fully understand the relationship between chemical exposure and endocrine health.
There is evidence of a connection between estrogenic effects at the receptor level and exposure to DEHP. The authors conclude that "the effects of DEHP in cell cultures support an estrogenic effect at the receptor level. Being a common problem, this subject deserves additional studies in larger case series to confirm our results and explain the cause-effect relationship" (Durmaz et al., 2010, p. e128). Without such larger studies, these connections and correlations remain preliminary. As previously noted, over 65% of adolescent males develop some degree of pubertal gynecomastia, and these numbers could increase if harmful chemicals in products and food remain unaddressed.
The study's final findings reinforce the need for continued investigation: "Plasma DEHP and MEHP levels were found to be significantly higher in patients with pubertal gynecomastia compared with control patients. Several studies that included humans as the subjects have demonstrated a possible estrogenic effect of DEHP besides antiandrogenic effects" (Durmaz et al., 2010, p. e128).
Durmaz, E., Ozmert, E. N., Giray, B., Derman, O., Hincal, F., & Yurdakok, K. (2010). Plasma phthalate levels in pubertal gynecomastia. Pediatrics, 125(1), e122–e129.
Always verify citation format against your institution’s current style guide requirements.